Abstract
Background
Surgeons commonly arrange for patients to perform autologous blood donation before elective orthopaedic surgery. Understanding sociodemographic patterns of use of autologous blood transfusion can help improve quality of care and cost containment.
Questions/purposes
We sought to determine whether there were (1) racial disparities, (2) insurance-based disparities, or (3) income-based disparities in autologous blood use. Additionally, we evaluated the combined effect of (4) race and insurance and (5) race and income on autologous blood use, and we compared ratios of autologous with allogeneic blood use.
Methods
Of the more than 3,500,000 patients undergoing major elective orthopaedic surgery identified in the Nationwide Inpatient Sample between 2008 and 2011, 2.4% received autologous blood transfusion and 12% received allogeneic blood transfusion. Multivariable logistic regression was performed to determine the influence of race, insurance status, and income on autologous blood use.
Results
Compared with white patients, Hispanic patients had lower odds of autologous blood use for elective hip (odds ratio [OR], 0.75; 95% CI, 0.69–0.82) and knee arthroplasties (OR, 0.71; 95% CI, 0.67–0.75). Black patients had lower odds of receiving autologous blood transfusion for hip arthroplasty (OR, 0.78; 95% CI, 0.74–0.83). Compared with the privately insured, uninsured and publicly insured patients were less likely to receive autologous blood for total joint arthroplasty and spinal fusion. Patients with low and medium income were less likely to have autologous blood transfusion for total joint arthroplasty and spinal fusion compared with high-level income earners. Even at comparable income and insurance levels with whites, Hispanic and black patients tended to be less likely to receive autologous blood transfusion. Ratios of autologous to allogeneic blood use were lower among minority patients.
Conclusions
Historically disadvantaged populations receive fewer autologous blood transfusions for elective orthopaedic surgery. Whether the differential use is attributable to patient preference or unequal access to this practice should be investigated further.
Level of Evidence
Level II, prognostic study. See the Instructions for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
Baker DW, Parker RM, Williams MV, Pitkin K, Parikh NS, Coates W, Imara M. The health care experience of patients with low literacy. Arch Fam Med. 1996;5:329–334.
Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81:2–10.
Bierman AS, Magari ES, Jette AM, Splaine M, Wasson JH. Assessing access as a first step toward improving the quality of care for very old adults. J Ambul Care Manage. 1998;21:17–26.
Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am. 2002;84-A:1299–1304.
Blustein J. The reliability of racial classifications in hospital discharge abstract data. Am J Public Health. 1994;84:1018–1021.
Boettner F, Altneu EI, Williams BA, Hepinstall M, Sculco TP. Nonanemic patients do not benefit from autologous blood donation before total hip replacement. HSS J. 2010;6:66–70.
Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013;28(8 suppl):34–37.
Bryant A, Mhyre JM, Leffert LR, Hoban RA, Yakoob MY, Bateman BT. The association of maternal race and ethnicity and the risk of postpartum hemorrhage. Anesth Analg. 2012;115:1127–1136.
Carless P, Moxey A, O’Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med. 2004;14:123–144.
Domen RE. Preoperative autologous blood donation: clinical, economic, and ethical issues. Cleve Clin J Med. 1996;63:295–300.
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.
Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med. 1998;158:610–616.
Franks P, Fiscella K. Reducing disparities downstream: prospects and challenges. J Gen Intern Med. 2008;23:672–677.
Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014;96:272–278.
Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: first of two parts—blood transfusion. N Engl J Med. 1999;340:438–447.
Green WS, Toy P, Bozic KJ. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. J Arthroplasty. 2010;25:93–96.
Hall EC, Boyarsky BJ, Deshpande NA, Garonzik-Wang JM, Berger JC, Dagher NN, Segev DL. Perioperative complications after live-donor hepatectomy. JAMA Surg. 2014;149:288–291.
Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty: an analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000;82:89–100.
Henry DA, Carless PA, Moxey AJ, O’Connell D, Forgie MA, Wells PS, Fergusson D. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2002:CD003602.
Kim S, Altneu E, Bou Monsef J, King EA, Sculco TP, Boettner F. Nonanemic patients do not benefit from autologous blood donation before total knee replacement. HSS J. 2011;7:141–144.
Kleinert K, Theusinger OM, Nuernberg J, Werner CM. Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery. HSS J. 2010;6:190–198.
Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Administrative databases: are they useful for clinical analyses? Anesthesiology. 2009;111:450; author reply 450–451.
Lee SJ, Liljas B, Churchill WH, Popovsky MA, Stowell CP, Cannon ME, Johannesson M. Perceptions and preferences of autologous blood donors. Transfusion. 1998;38:757–763.
Lillie-Blanton M, Brodie M, Rowland D, Altman D, McIntosh M. Race, ethnicity, and the health care system: public perceptions and experiences. Med Care Res Rev. 2000;57(suppl 1):218–235.
Lin CA, Kuo AC, Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95:1028–1036.
Memtsoudis SG. Limitations associated with the analysis of data from administrative databases. Anesthesiology. 2009;111:449; author reply 450–451.
Memtsoudis SG, Ma Y, Chiu YL, Walz JM, Voswinckel R, Mazumdar M. Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg. 2010;111:1110–1116.
Menendez ME, Neuhaus V, Bot AG, Ring D, Cha TD. Psychiatric disorders and major spine surgery: epidemiology and perioperative outcomes. Spine (Phila Pa 1976). 2014;39:E111–122.
Moxey AJ, O’Connell DL, Treloar CJ, Han PY, Henry DA. Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members and the public. Transfus Med. 2005;15:19–32.
Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am. 2014;96:279–284.
Nguyen GC, Patel AM. Racial disparities in mortality in patients undergoing bariatric surgery in the U.S.A. Obes Surg. 2013;23:1508–1514.
Park JH, Rasouli MR, Mortazavi SM, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013;95:1777–1783.
Paskett ED, Rushing J, D’Agostino R Jr, Tatum C, Velez R. Cancer screening behaviors of low-income women: the impact of race. Womens Health. 1997;3:203–226.
Rasouli MR, Maltenfort MG, Purtill JJ, Hozack WJ, Parvizi J. Has the rate of in-hospital infections after total joint arthroplasty decreased? Clin Orthop Relat Res. 2013;471:3102–3111.
Saha S, Arbelaez JJ, Cooper LA. Patient-physician relationships and racial disparities in the quality of health care. Am J Public Health. 2003;93:1713–1719.
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections: the Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334:1685–1690.
Segal JB, Guallar E, Powe NR. Autologous blood transfusion in the United States: clinical and nonclinical determinants of use. Transfusion. 2001;41:1539–1547.
Shortt NL, Robinson CM. Mortality after low-energy fractures in patients aged at least 45 years old. J Orthop Trauma. 2005;19:396–400.
Taub DA, Hollenbeck BK, Cooper KL, Dunn RL, Miller DC, Taylor JM, Wei JT. Racial disparities in resource utilization for cystectomy. Urology. 2006;67:288–293.
Tseng VL, Yu F, Lum F, Coleman AL. Risk of fractures following cataract surgery in Medicare beneficiaries. JAMA. 2012;308:493–501.
Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113:3406–3417.
Wallace AE, Young-Xu Y, Hartley D, Weeks WB. Racial, socioeconomic, and rural-urban disparities in obesity-related bariatric surgery. Obes Surg. 2010;20:1354–1360.
Williams TK, Schneider EB, Black JH 3rd, Lum YW, Freischlag JA, Perler BA, Abularrage CJ. Disparities in outcomes for Hispanic patients undergoing endovascular and open abdominal aortic aneurysm repair. Ann Vasc Surg. 2013;27:29–37.
Wong JC, Torella F, Haynes SL, Dalrymple K, Mortimer AJ, McCollum CN; ATIS Investigators. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann Surg. 2002;235:145–151.
Yoshihara H, Yoneoka D. Trends in the utilization of blood transfusions in spinal fusion in the United States from 2000 to 2009. Spine (Phila Pa 1976). 2014;39:297–303.
Yoshihara H, Yoneoka D. Predictors of Allogeneic Blood Transfusion in Spinal Fusion in the United States, 2004–2009. Spine (Phila Pa 1976). 2014;39:304–310.
Author information
Authors and Affiliations
Corresponding author
Additional information
Each author certifies that he or she, or a member of his or her immediate family, has no funding or commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research ® editors and board members are on file with the publication and can be viewed on request.
Each author certifies that his or her institution waived approval for the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.
About this article
Cite this article
Menendez, M.E., Ring, D. Minorities Are Less Likely to Receive Autologous Blood Transfusion for Major Elective Orthopaedic Surgery. Clin Orthop Relat Res 472, 3559–3566 (2014). https://doi.org/10.1007/s11999-014-3793-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-014-3793-5